Spero Therapeutics, Inc. (SPRO): Price and Financial Metrics
SPRO Price/Volume Stats
| Current price | $0.98 | 52-week high | $1.89 |
| Prev. close | $1.00 | 52-week low | $0.92 |
| Day low | $0.96 | Volume | 266,400 |
| Day high | $1.02 | Avg. volume | 185,067 |
| 50-day MA | $1.14 | Dividend yield | N/A |
| 200-day MA | $1.34 | Market Cap | 53.43M |
SPRO Stock Price Chart Interactive Chart >
Spero Therapeutics, Inc. (SPRO) Company Bio
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel treatments for multi-drug resistant (MDR) bacterial infections in the United States. It is developing SPR994, an oral carbapenem-class antibiotic for use in adults to treat MDR gram-negative infections; SPR741 that has completed Phase I clinical trial to treat MDR gram-negative infections in the hospital setting; SPR206, an agent that is in preclinical development stage to disrupt the outer membrane of gram-negative bacteria; and SPR720, an oral antibiotic that is in preclinical development stage for the treatment of pulmonary non-tuberculous mycobacterial infections. The company was founded in 2013 and is based in Cambridge, Massachusetts.
SPRO Price Returns
| 1-mo | -8.41% |
| 3-mo | -18.33% |
| 6-mo | -33.78% |
| 1-year | -32.41% |
| 3-year | -92.58% |
| 5-year | -89.27% |
| YTD | -4.85% |
| 2024 | -29.93% |
| 2023 | -15.03% |
| 2022 | -89.19% |
| 2021 | -17.43% |
| 2020 | 101.66% |
Continue Researching SPRO
Want to do more research on Spero Therapeutics Inc's stock and its price? Try the links below:Spero Therapeutics Inc (SPRO) Stock Price | Nasdaq
Spero Therapeutics Inc (SPRO) Stock Quote, History and News - Yahoo Finance
Spero Therapeutics Inc (SPRO) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...